2013 Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gahrton G Journal Blood
2013 Comparison of allogeneic stem cell transplantation and non-transplant approaches in elderly patients with advanced myelodysplastic syndrome: optimal statistical approaches and a critical appraisal of clinical results using non-randomized data Group Chronic Malignancies Working Party (CMWP) 1st listed author Brand R Journal PLos One
2013 Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Auner HW Journal Bone Marrow Transplant.
2012 Monosomal karyotype predicts poor survival after allogeneic stem cell transplantation in chromosome 7 abnormal myelodysplastic syndrome and secondary acute myeloid leukemia. Group Chronic Malignancies Working Party (CMWP) 1st listed author van Gelder M Journal Leukemia
2012 Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Ruutu T Journal Bone Marrow Transplant.
2012 Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Garderet L Journal J Clin Oncol.
2012 Autologous and allogeneic stem-cell transplantation for transformed chronic lymphocytic leukemia (Richter’s syndrome): A retrospective analysis from the chronic lymphocytic leukemia subcommittee of the chronic leukemia working party and lymphoma working party of the European Group for Blood and Marrow Transplantation. Group Lymphoma Working Party (LWP) Chronic Malignancies Working Party (CMWP) 1st listed author Cwynarski K Journal J Clin Oncol.
2012 Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT. Group Acute Leukemia Working Party (ALWP) Chronic Malignancies Working Party (CMWP) 1st listed author Martino R Journal Bone Marrow Transplant.
2012 Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Basak GW Journal Bone Marrow Transplant.
2012 Hematopoietic stem cell transplantation in T-prolymphocytic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation and the Royal Marsden Consortium. Group Chronic Malignancies Working Party (CMWP) 1st listed author Wiktor-Jedrzejczak W Journal Leukemia
2011 Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosis. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal Haematologica
2011 Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure? Group Chronic Malignancies Working Party (CMWP) 1st listed author de Witte T Journal Clin Lymphoma Myeloma Leuk.